Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Consultas o comentarios: productividad@anid.cl
Pembrolizumab in HER2-Positive Gastric Cancer
| Indexado |
|
||||
| DOI | 10.1056/NEJMC2408121 | ||||
| Año | 2024 | ||||
| Tipo |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Abstract
Pembrolizumab in HER2-Positive Gastric Cancer The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Janjigian, Yelena Y. | Mujer |
Mem Sloan Kettering Canc Ctr - Estados Unidos
Memorial Sloan-Kettering Cancer Center - Estados Unidos |
| 2 | Kawazoe, Akihito | Hombre |
Natl Canc Hosp East - Japón
National Cancer Center Hospital East - Japón |
| 3 | CORREA-ALLENDE, CATALINA | Mujer |
Harbin Med Univ Canc Hosp - China
Harbin Med Univ - China Harbin Medical University - China |
| 4 | Xu, Jianming | - |
Peoples Liberat Army - China
The Sixth Medical Center of People’s Liberation Army General Hospital - China |
| 4 | Xu, Jianming | - |
Fifth Med Ctr Peoples Liberat Army - China
|
| 5 | Lonardi, Sara | - |
Ist Oncol Veneto - Italia
|
| 5 | Lonardi, Sara | Mujer |
Ist Oncolog Veneto - Italia
Istituto Oncologico Veneto IOV - IRCCS - Italia |
| 6 | Metges, Jean Phillipe | Hombre |
Univ Hosp Brest - Francia
Centre Hospitalier Universitaire de Brest - Francia |
| 7 | Yanez, Patricio | - |
James Lind Canc Res Ctr - Chile
|
| 7 | Yanez, Patricio | - |
James Lind Canc Res Ctr - Chile
James Lind Cancer Research Center - Chile |
| 8 | Wyrwicz, Lucjan S. | - |
Maria Sklodowska Curie Natl Canc Res Inst - Polonia
Maria Sklodowska-Curie National Cancer Research Institute - Polonia |
| 9 | Shen, Lin | - |
Key Lab Carcinogenesis & Translat Res - China
Key Laboratory of Carcinogenesis and Translational Research - China |
| 10 | Ostapenko, Yuriy | Hombre |
Natl Canc Inst - Ucrania
National Cancer Institute of Ukraine - Ucrania |
| 11 | Bilici, Mehmet | - |
Ataturk Univ - Turquía
Atatürk Üniversitesi - Turquía |
| 12 | Chung, Hyun-Cheol | - |
Yonsei Canc Ctr - Corea del Sur
Yonsei Cancer Hospital - Corea del Sur |
| 13 | Shitara, Kohei | - | |
| 13 | Shitara, Kohei | Hombre |
Natl Canc Hosp East - Japón
National Cancer Center Hospital East - Japón |
| 14 | Qin, Shukui | - |
Peoples Liberat Army - China
Cancer Center of People's Liberation Army - China |
| 14 | Qin, Shukui | - |
Canc Ctr Peoples Liberat Army - China
|
| 15 | Van Cutsem, Eric | Hombre |
Univ Hosp Gasthuisberg - Bélgica
KU Leuven– University Hospital Leuven - Bélgica |
| 16 | Tabernero, J. | Hombre |
Vall dHebron Univ Hosp Inst Oncol - España
Hospital Universitari Vall d'Hebron - España |
| 16 | Tabernero, Josep | - |
Vall dHebron Univ Hosp - España
|
| 17 | Luo, Suxia | - |
Henan Canc Hosp - China
Henan Cancer Hospital - China |
| 18 | Mahave, Mauricio | Hombre |
Fdn Arturo Lopez Perez - Chile
Fundación Arturo López Pérez - Chile |
| 19 | Tang, Yong | - |
Xinjiang Med Univ - China
Xinjiang Medical University - China |
| 20 | Lowery, Maeve | - |
Trinity St Jamess Canc Inst - Irlanda
Trinity St James’s Cancer Institute - Irlanda |
| 21 | Monteiro, Maria M. F. | - |
Inst Canc Ceara - Brasil
Instituto do Câncer do Ceará - Brasil |
| 22 | Xu, Linzhi | - |
Merck - Estados Unidos
Merck & Co., Inc. - Estados Unidos |
| 23 | Shih, Chie Schin | Mujer |
Merck - Estados Unidos
Merck & Co., Inc. - Estados Unidos |
| 24 | Sharan, Kanu P. | - |
Merck - Estados Unidos
Merck & Co., Inc. - Estados Unidos |
| 25 | Bhagia, Pooja | Mujer |
Merck - Estados Unidos
Merck & Co., Inc. - Estados Unidos |
| 26 | Rha, Sun Young | - |
Yonsei Canc Ctr - Corea del Sur
Yonsei Cancer Hospital - Corea del Sur |
| Fuente |
|---|
| National Institutes of Health |
| National Cancer Institute |
| Merck Sharp and Dohme |
| Merck Sharp and Dohme K.K. |
| Cancer Center Support Grant from the National Cancer Institute of the National Institutes of Health |
| Agradecimiento |
|---|
| Supported by Merck Sharp and Dohme and by a Cancer Center Support Grant (P30 CA008748, to Memorial Sloan Kettering Cancer Center) from the National Cancer Institute of the National Institutes of Health. |
| Supported by Merck Sharp and Dohme and by a Cancer Center Support Grant (P30 CA008748, to Memorial Sloan Kettering Cancer Center) from the National Cancer Institute of the National Institutes of Health. |
| Supported by Merck Sharp and Dohme and by a Cancer Center Support Grant (P30 CA008748, to Memorial Sloan Kettering Cancer Center) from the National Cancer Institute of the National Institutes of Health . |
